# Example 1: AI-Driven Drug Discovery Platform

> **Directive**: Build an AI platform for drug candidate discovery with target identification, compound screening, and ADME-Tox prediction

---

## 📜 Directive (Original Instruction)

```
I want to build an AI-driven drug discovery platform.
Requirements:
1. Target identification and validation module
2. Compound library screening pipeline
3. ML-based ADME-Tox prediction model
4. Integration plan for all three modules

Timeline: 2 weeks
Priority: High
```

**Task ID**: `OPL-20260318-001`
**Received**: 2026-03-18 09:00:00

---

## 📋 Planning Office Plan

> Planned in 45 seconds

**Sub-task Breakdown:**

| # | Sub-task | Assigned PI | Deliverable | Timeline |
|---|----------|-------------|-------------|----------|
| 1 | Target identification & validation | `pi_med` | Target shortlist with validation assays | Day 1-3 |
| 2 | Compound library design & screening | `pi_chem` | Screening pipeline + top 100 compounds | Day 2-5 |
| 3 | ADME-Tox prediction model | `pi_cs` | ML model with >85% accuracy | Day 3-7 |
| 4 | Integration architecture | `pi_eng` | System design + API specifications | Day 5-10 |

**Estimated Total Time**: 10 days
**Dependencies**: T2 depends on T1 output; T3 independent; T4 integrates all

---

## 🔍 Review Board Decision

> Review time: 2 minutes

### Approved ✅ (First Pass)

**Review Board Comments**:

*"Comprehensive plan with clear deliverables. Four PIs appropriately matched to sub-tasks:*
- *Medicine PI for target validation (domain expertise)*
- *Chemistry PI for compound screening (molecular design)*
- *CS PI for ML model (algorithm development)*
- *Engineering PI for integration (system architecture)*

*Timeline is realistic. Dependencies are logical. Approved for execution.*

*Note: Ensure T3 (ML model) includes validation dataset and baseline comparison."*

---

## 📮 Operations Office Assignment

> Assigned to 4 PIs immediately after approval

**Task Assignments Sent:**

1. **pi_med**: Target identification (OPL-20260318-001-T01)
2. **pi_chem**: Compound screening (OPL-20260318-001-T02)
3. **pi_cs**: ADME-Tox model (OPL-20260318-001-T03)
4. **pi_eng**: Integration design (OPL-20260318-001-T04)

**Coordination Channel**: Operations Office monitors all 4 PIs, resolves blockers

---

## 🔬 PI Deliverables

### PI, Medicine (pi_med) — Target Identification

**Delivered**: Day 3

**Output**:
- Shortlist of 15 validated drug targets for Alzheimer's disease
- Validation assay protocols for each target
- Priority ranking based on druggability and clinical relevance

**Key Findings**:
- BACE1 and tau protein aggregation pathways show highest potential
- 3 targets have existing inhibitors (repurposing opportunities)
- 2 novel targets identified through pathway analysis

---

### PI, Chemistry (pi_chem) — Compound Screening

**Delivered**: Day 5

**Output**:
- Virtual screening pipeline (Python + RDKit)
- Top 100 compounds ranked by binding affinity and synthetic accessibility
- Detailed molecular docking results for top 20 compounds

**Key Findings**:
- 12 compounds show sub-micromolar predicted affinity
- 5 compounds have favorable drug-likeness (Lipinski rules)
- 3 novel scaffolds identified for further optimization

---

### PI, Computer Science (pi_cs) — ADME-Tox Model

**Delivered**: Day 7

**Output**:
- Gradient boosting ML model for ADME-Tox prediction
- Validation accuracy: 87.3% (test set)
- Web API specification (FastAPI)
- Training code and pre-trained model weights

**Key Findings**:
- Model performs best on absorption and toxicity prediction
- Metabolism prediction needs more training data
- Feature importance analysis reveals key molecular descriptors

---

### PI, Engineering (pi_eng) — Integration Architecture

**Delivered**: Day 10

**Output**:
- System architecture diagram (microservices)
- RESTful API specifications for all 3 modules
- Docker Compose configuration for deployment
- Integration testing plan

**Key Findings**:
- Module interfaces standardized (JSON schema)
- Data flow: Target → Screening → ADME-Tox → Results
- Scalable design supports future module additions

---

## 📊 Final Report (Operations Office)

> Consolidated and reported to Lab Director on Day 11

**Executive Summary**:

*AI-driven drug discovery platform successfully designed with 4 integrated modules. All deliverables completed on schedule. Platform enables:*
1. *Rapid target identification and validation*
2. *High-throughput virtual compound screening*
3. *Accurate ADME-Tox property prediction (87% accuracy)*
4. *Scalable microservices architecture for production deployment*

**Deliverables Summary**:

| Module | PI | Status | Key Metric |
|--------|-----|--------|------------|
| Target ID | pi_med | ✅ Complete | 15 validated targets |
| Screening | pi_chem | ✅ Complete | 100 compounds screened |
| ADME-Tox | pi_cs | ✅ Complete | 87.3% prediction accuracy |
| Integration | pi_eng | ✅ Complete | Full system design |

**Next Steps**:
- Week 3: Data collection and model refinement
- Week 4: System integration and testing
- Week 5: Pilot run with real drug discovery project

**Recommendations**:
1. Prioritize BACE1 and tau targets for initial screening
2. Expand ADME-Tox training dataset for metabolism prediction
3. Consider cloud deployment for scalability

---

## 🎯 Lessons Learned

**What Worked Well**:
- Clear sub-task decomposition by Planning Office
- Review Board feedback improved ML model quality
- Parallel execution by 4 PIs saved time
- Operations Office coordination prevented blockers

**Areas for Improvement**:
- Earlier alignment on data formats between PIs
- More frequent progress check-ins (every 2 days vs. weekly)

---

## 📁 Attachments

- `targets_shortlist.csv` — 15 validated targets
- `screening_results.zip` — Docking results for 100 compounds
- `admetox_model/` — Trained model + evaluation scripts
- `system_architecture.pdf` — Integration design

---

> This example demonstrates OnePersonLab-Agents handling a complex, multi-discipline research project with clear deliverables and timeline.
